Roche· @Roche · X·· 2026-10-02AI 评分8
AI 导读
要推动视网膜诊疗进步,我们必须了解解决方案在日常实践中的表现。 随着@EURETINA 2026持续进行,罗氏眼科治疗领域负责人Nilesh Mehta正在分享我们最新的真实世界证据对新生血管性年龄相关性黄斑变性(#nAMD)和糖尿病性黄斑水肿(#DME)患者可能意味着什么。 #EURETINA26
正文
To move retinal care forward, we must understand how solutions perform in everyday practice.
As @EURETINA 2026 continues, Nilesh Mehta, Therapeutic Area Head, Ophthalmology at Roche, is sharing what our latest real-world evidence could mean for patients with neovascular age-related macular degeneration (#nAMD) and diabetic macular edema (#DME).
#EURETINA26
来源:Roche · x.com